Clinical Trials Logo

Filter by:
NCT ID: NCT04043663 Recruiting - Emergence Delirium Clinical Trials

Effects of Virtual Reality on Perioperative Pediatric Anxiety

VIRTUALPED
Start date: July 15, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effect of virtual reality on anxiety levels in a pediatric surgical population. Half of participants will receive standard perioperative treatment, while the other half will receive additionally a virtual reality local program.

NCT ID: NCT04043494 Recruiting - Clinical trials for Lymphoblastic Lymphoma, Childhood

International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

LBL 2018
Start date: August 23, 2019
Phase: Phase 3
Study type: Interventional

Primary objectives: - Randomization R1, all patients eligible: To examine, whether the cumulative incidence of relapses with involvement of the CNS (CNS relapse, pCICR) can be decreased by a modified induction therapy including dexamethasone (experimental arm) instead of prednisone (standard arm) - Randomization R2, only patients with high risk LBL eligible: to examine, whether the probability of event-free survival (pEFS) in these patients can be improved by receiving an intensified treatment arm versus a standard treatment arm (as used in the EURO-LB 02)

NCT ID: NCT04042701 Recruiting - Breast Cancer Clinical Trials

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer

Start date: February 10, 2020
Phase: Phase 1
Study type: Interventional

This two-part study will include a dose escalation part to determine the recommended dose for expansion of DS8201a and pembrolizumab and a dose expansion part to evaluate efficacy, safety, and tolerability of the combination.

NCT ID: NCT04042155 Recruiting - Atrial Fibrillation Clinical Trials

Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)

MACACOD
Start date: July 29, 2019
Phase:
Study type: Observational [Patient Registry]

MACACOD is a clinical record in the usual clinical practice of direct oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban). Design: single-center, observational, prospective, uncontrolled study of anticoagulated patients with any direct oral anticoagulant (DOAC) with atrial fibrillation or venous thromboembolism to determine the incidence of serious complications (thromboembolic or hemorrhagic) in real life

NCT ID: NCT04042038 Recruiting - Clinical trials for Obsessive-Compulsive Disorder (OCD)

Neural Predictors and Neural Changes Associated With Cognitive Behavior Therapy for Obssesive Compulsive Disorder

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

The goals of the project are 1) to understand what are the neural mechanisms involved in the psychological treatment of obsessive-compulsive disorder (OCD) in children/adolescents and adults, 2) to assess potential differences in the neural mechanisms involved in the psychological treatment of OCD between children/adolescents and adults, and 3) to assess the effectiveness of intensive CBT for children/adolescents and adults with OCD.

NCT ID: NCT04041635 Recruiting - Premature Clinical Trials

Reduction of Visual and Auditory Stimuli to Reduce Pain During Venipuncture in Premature Infants.

VENOPUNCIPREM
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The aim of the study is: To evaluate the efficacy of the reduction of visual and auditory stimuli on pain during venipuncture in premature newborns of 32-36 weeks of gestation.

NCT ID: NCT04041310 Recruiting - Solid Tumor, Adult Clinical Trials

Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Start date: October 21, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Ref: Protocol v9.0, dated 7Nov2023. NOUS-209-01 is a multicenter, open-label, multiple cohorts, clinical study, designed to evaluate safety, tolerability, and immunogenicity, and to detect any preliminary evidence of anti-tumor activity of Nous-209 genetic polyvalent vaccine plus pembrolizumab combination therapy in adult subjects with unresectable or metastatic deficient mismatch repair (dMMR) or MSI-H CRC, gastric, or gastro-esophageal junction (G-E junction) tumors. Nous-209 is based on a heterologous prime/boost regimen composed of the Great Ape Adenovirus GAd20-209-FSP used for priming and Modified Vaccinia virus Ankara MVA-209-FSP used for boosting. The Phase I portion of the study is a first-in-human (FIH) clinical study with a primary objective to elucidate the safety and tolerability of Nous-209 in addition to establishing the recommended Phase 2 dose (RP2D), whereas the Phase II was introduced to assess efficacy as the primary objective.

NCT ID: NCT04040283 Recruiting - Meniscus Lesion Clinical Trials

Platelet-rich Plasma for Menical Tear

Start date: January 2014
Phase:
Study type: Observational

Meniscal injuries are a common pathology among athletes, and have an impact on the daily or sporting practice of patients. Surgical approach implies sometimes heavy consequences. Platelet-rich-plasma (PRP) has been shown to be effective in accelerating wound healing and tissue regeneration in orthopedic and oral surgery. This clinical trial aims to investigate the safety and efficacy of intraarticular and periferal PRP injection in patients with stable meniscal injury. The pre- and post-interventional clinical outcomes will be compared.

NCT ID: NCT04039893 Recruiting - Clinical trials for Node-positive Breast Cancer

MUltimodal Targeted Axillary Surgery

MUTAS
Start date: October 23, 2019
Phase: N/A
Study type: Interventional

The present trial will prospectively evaluate the accuracy of both a systematic predefined axillary ultrasound imaging together with tumor load quantification of suspicious and sentinel axillary lymph nodes to predict overall tumor load in the axilla.

NCT ID: NCT04039659 Recruiting - Clinical trials for Liver Transplant; Complications

POstoperative Negative-pressure Incision Therapy Following LIver TRANSplant:a Randomized Controlled Trial

PONILITRANS
Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This study is to evaluate whether the prophylactic use of a negativa pressure therapy device (PICOⓇ) on the closed wound of the liver transplant, reduces the postoperative complications of surgical wounds, compared to the use of dressings conventional postoperative